세계의 트립타민 API 시장(2025-2032년) : 업계 분석, 규모, 점유율, 성장, 동향, 예측

Tryptamines API Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 7,030,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,267,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,956,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

세계 트립타민 API 시장 규모는 2025년에 8억 4,300만 달러에 달할 것으로 예상되며, 2025-2032년의 예측 기간 동안 11.2%의 연평균 복합 성장률(CAGR)로 성장하여 2032년에는 17억 7,240만 달러에 달할 것으로 예측되고 있습니다.

트립타민은 아미노산의 트립토판과 구조적으로 관련된 화합물의 일종이며, 신경전달물질이나 환각 화합물 등 다양한 생물학적 활성물질의 화학적 골격으로서 기능합니다. 트립타민 API 시장은 제약 제조업체, 연구 개발기관, 개발 및 제조 수탁기관(CDMO)을 대상으로 하고 있으며, 합성 및 천연 유래의 트립타민 화합물에 대한 주목이 높아지고 있습니다.

세계의 트립타민 API 시장은 정신 질환의 세계적인 부담 증가와 새롭고 즉각적인 치료제에 대한 요구 등 몇 가지 중요한 요인에 의해 추진되고 있습니다. 트립타민 유도체를 지지하는 임상 증거가 늘어나면서 시장에 대한 인기와 투자가 증가하고 있습니다. 환각제 연구와 정신 건강 치료제의 신속한 승인 허가를 지지하는 규제의 변화도 시장의 가속화에 기여하고 있습니다.

트립타민 API 시장은 유망한 시장임에도 불구하고 규제적 제약, 사회적 낙인, 높은 시장 개척 비용 등의 과제에 직면하고 있습니다. 또한 시장 투입까지는 오랜 시간이 소모됩니다. 또한, 오용의 가능성이나 심리적 악영향 등의 안전성에 대한 우려로 인해 엄격한 임상 프로토콜과 환자의 모니터링이 필요하므로 시장 관계자의 운영 비용과 위험에 대한 노출이 증가합니다.

트립타민 API 시장은 정신 건강 치료에 관한 연구 개발의 확대, 유리한 시장 개척, 혁신적인 중추신경계(CNS) 치료에 대한 수요 증가 등으로 큰 기회를 가지고 있습니다. 합성 기술의 진보로 비용효과적이고 확장 가능한 원약 생산이 가능해지고 있습니다. 또한, 맞춤형 정신의학이나 마이크로도징 요법에 대한 관심의 증가로 큰 가능성을 비롯한 틈새 시장을 형성하고 있습니다. 전략적 제휴, 라이선스 계약, 임상시험에 대한 투자는 이러한 새로운 기회를 활용하는 데 필수적입니다.

본 보고서는 세계의 트립타민 API 시장에 대해 조사했으며, 등급별, 유래별, 용도별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

제3장 주요 시장 동향

제4장 부가가치 통찰력

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• 시장 시나리오(2022년)
• COVID-19와 영향 분석

제7장 세계의 트립타민 API 시장 전망(2019-2032년)

• 과거 시장 규모 분석(2019-2024년)
• 현재 및 미래 시장 규모 예측(2025-2032년)
  • 전년 대비 성장 동향 분석

제8장 세계의 트립타민 API 시장 전망(2019-2032년)

• 지역 가격 분석
• 가격 분석
• 세계 평균 가격 분석 벤치마크

제9장 세계의 트립타민 API 시장 전망(2019-2032년)

• 과거 시장 규모(100만 달러) 분석(2019-2024년)
• 현재 및 미래 시장 규모(100만 달러) 예측(2025-2032년)

제10장 세계의 트립타민 API 시장 전망(2019-2032년), 등급별

• 소개/주요 조사 결과
• 과거 시장 규모(100만 달러) 분석, 등급별(2019-2024년)
• 현재 및 미래 시장 규모(100만 달러) 예측, 등급별(2025-2032년)
  • GMP 등급
  • 비 GMP 등급
• 시장의 매력 분석, 등급별

제11장 세계의 트립타민 API 시장 전망(2019-2032년), 유래별

• 소개/주요 조사 결과
• 과거 시장 규모(100만 달러) 분석, 유래별(2019-2024년)
• 현재 및 미래 시장 규모(100만 달러) 예측, 유래별(2025-2032년)
  • 천연
  • 합성
  • 생합성
• 시장의 매력 분석, 유래별

제12장 세계의 트립타민 API 시장 전망(2019-2032년), 용도별

• 소개/주요 조사 결과
• 과거 시장 규모(100만 달러) 분석, 용도별(2019-2024년)
• 현재 및 미래 시장 규모(100만 달러) 예측, 용도별(2025-2032년)
  • 임상
  • 연구
• 시장의 매력 분석, 용도

제13장 세계의 트립타민 API 시장 전망(2019-2032년), 지역별

• 소개
• 과거 시장 규모(100만 달러) 분석, 지역별(2019-2024년)
• 현재 및 미래 시장 규모(100만 달러) 예측, 지역별(2025-2032년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카
• 시장의 매력 분석, 지역별

제14장 북미의 트립타민 API 시장 전망(2019-2032년)

제15장 라틴아메리카의 트립타민 API 시장 전망(2019-2032년)

제16장 유럽의 트립타민 API 시장 전망(2019-2032년)

제17장 남아시아의 트립타민 API 시장 전망(2019-2032년)

제18장 동아시아의 트립타민 API 시장 전망(2019-2032년)

제19장 오세아니아의 트립타민 API 시장 전망(2019-2032년)

제20장 중동 및 아프리카의 트립타민 API 시장 전망(2019-2032년)

제21장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁의 상세
  • Merck
  • Avra Synthesis Private Limited
  • Spectrum Chemical
  • Cayman Chemical Company(Matreya)
  • Tokyo Chemical Industry Co. Ltd.
  • Santa Cruz Biotechnology, Inc.
  • LGC Standards
  • Avra Synthesis Private Limited
  • SimSon Pharma Limited
  • Glentham Life
  • Clearsynth Labs
  • Otto Chemie Pvt. Ltd
  • Pharmaffiliates Analytics and Synthetics P. Ltd.
  • Psygen
  • Biosynth

제22장 전제와 약어 설명

제23장 조사 방법

CSM

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for tryptamines active pharmaceutical ingredients (APIs). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global tryptamines API market from 2025 to 2032.

Key Insights:

• Tryptamines API Market Size (2025E): USD 843.0 Million
• Projected Market Value (2032F): USD 1,772.4 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 11.2%

Tryptamines API Market - Report Scope:

Tryptamines are a class of compounds structurally related to the amino acid tryptophan, and they serve as the chemical backbone for a range of biologically active substances, including neurotransmitters and psychedelic compounds. In pharmaceutical applications, tryptamines APIs are utilized in the development of treatments for mental health conditions such as depression, anxiety, and PTSD, as well as for neurological and cognitive disorders. The tryptamines API market caters to pharmaceutical manufacturers, research institutions, and contract development and manufacturing organizations (CDMOs), with a growing focus on both synthetic and naturally derived tryptamine compounds. Market growth is driven by the rising interest in psychedelic-assisted therapy, increased mental health awareness, and advances in neuroscience and psychopharmacology.

Market Growth Drivers:

The global tryptamines API market is propelled by several critical factors, including the rising global burden of mental health disorders and the need for novel, fast-acting therapeutics. Growing clinical evidence supporting the use of tryptamine derivatives like psilocybin and DMT in managing depression and PTSD has significantly increased pharmaceutical interest and investment in this space. Regulatory shifts favoring psychedelic drug research and fast-track approvals for mental health therapies are also contributing to market acceleration. Additionally, partnerships between biotechnology companies and academic institutions are fostering innovation in API development and scalable production techniques, further fueling growth.

Market Restraints:

Despite promising prospects, the tryptamines API market faces challenges related to regulatory constraints, societal stigma, and high development costs. The legal classification of many tryptamines as controlled substances in several regions poses significant barriers to research, production, and commercialization. Complex and lengthy approval processes for psychedelic drug trials also slow down time-to-market. Moreover, safety concerns, such as potential misuse or adverse psychological effects, necessitate rigorous clinical protocols and patient monitoring, increasing operational costs and risk exposure for market players. These factors, combined with ethical debates surrounding psychedelic therapies, could hamper broader market adoption.

Market Opportunities:

The tryptamines API market presents substantial opportunities driven by expanding research on mental health treatments, favorable regulatory developments, and rising demand for innovative CNS (central nervous system) therapies. The decriminalization and legalization movements in various countries are opening new avenues for commercial manufacturing and therapeutic applications. Technological advancements in synthetic biology, precision fermentation, and chemical synthesis are enabling cost-effective and scalable API production. Furthermore, the growing interest in personalized psychiatry and microdosing therapies creates niche markets with significant potential. Strategic collaborations, licensing agreements, and investment in clinical trials are vital for leveraging these emerging opportunities.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the tryptamines API market globally?
• Which types of tryptamines APIs are gaining traction across therapeutic applications?
• How are regulatory trends and clinical research shaping the future of psychedelic drug development?
• Who are the key players in the tryptamines API market, and what strategies are they adopting to gain market advantage?
• What are the emerging trends and long-term growth opportunities in the global tryptamines API market?

Competitive Intelligence and Business Strategy:

Leading players in the global tryptamines API market, including Usona Institute, COMPASS Pathways plc, MindMed, CaaMTech, and Filament Health, are focusing on R&D, intellectual property strategies, and regulatory engagement to establish leadership in this evolving market. These companies are investing in scalable API production technologies, synthetic route optimization, and clinical development of tryptamine-based drug candidates. Collaborations with academic centers, healthcare providers, and government agencies are enhancing the credibility and clinical adoption of psychedelic-assisted therapies. Moreover, companies are prioritizing sustainability, traceability, and GMP-compliant manufacturing practices to ensure quality and regulatory adherence in the development of pharmaceutical-grade tryptamines APIs.

Key Companies Profiled:

• Merck
• Avra Synthesis Private Limited
• Spectrum Chemical
• Cayman Chemical Company (Matreya)
• Tokyo Chemical Industry Co. Ltd.
• Santa Cruz Biotechnology, Inc.
• LGC Standards
• Avra Synthesis Private Limited
• SimSon Pharma Limited
• Glentham Life
• Clearsynth Labs
• Otto Chemie Pvt. Ltd
• Pharmaffiliates Analytics and Synthetics P. Ltd.
• Psygen
• Biosynth

Key Segments of Tryptamines API Industry Research

Grade:

• GMP Grade
• Non-GMP Grade

Source:

• Natural
• Synthetic
• Bio-Synthetic

Application:

• Clinical Use
• Research Use

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage/Taxonomy
• 2.2. Market Definition/Scope/Limitations
• 2.3. Inclusion And Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Development/Innovation Trends

4. Value Added Insights

• 4.1. Production Capacity
• 4.2. Volume Consumption
• 4.3. Pricing Structure Assessment ($/Year)
  • 4.3.1. Raw Material
  • 4.3.2. Labor
  • 4.3.3. Facility Overhead
  • 4.3.4. Laboratory/QC/QA
  • 4.3.5. Consumables
  • 4.3.6. Utilities
• 4.4. Regulatory Scenario
• 4.5. Pipeline Assessment
• 4.6. Patent Analysis
• 4.7. PESTEL Analysis
• 4.8. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Industry Outlook
  • 5.1.3. Global API Manufacturing Overview
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Growing Incidence of Neurological and Psychiatric Diseases
  • 5.2.2. Applications of Tryptamines in Immunotherapy
  • 5.2.3. Growing R&D on Antitumor Therapy
  • 5.2.4. Global Growth of CDMOs
  • 5.2.5. Rising Clinical Studies Using Tryptamines
  • 5.2.6. Rising Demand from Downstream Industries
  • 5.2.7. Raw Material Costs
  • 5.2.8. Key Regulatory Dynamics
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. 2022 Market Scenario
• 6.2. COVID-19 and Impact Analysis
  • 6.2.1. By Grade
  • 6.2.2. By Source
  • 6.2.3. By Compound
  • 6.2.4. By Application
  • 6.2.5. By Region

7. Global Tryptamines API Market Outlook, 2019-2032

• 7.1. Historical Market Volume (Units) Analysis, 2019-2024
• 7.2. Current and Future Market Volume (Units) Projections, 2025-2032
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Tryptamines API Market Outlook, 2019-2032

• 8.1. Regional Pricing Analysis
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark
  • 8.3.1. Pricing Assumptions

9. Global Tryptamines API Market Outlook, 2019-2032

• 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Tryptamines API Market Outlook, 2019-2032, By Grade

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Trend Analysis , By Grade, 2019-2024
• 10.3. Current and Future Market Size (US$ Mn) Trend Analysis Forecast, By Grade, 2025-2032
  • 10.3.1. GMP Grade
  • 10.3.2. Non-GMP Grade
• 10.4. Market Attractiveness Analysis By Grade

11. Global Tryptamines API Market Outlook, 2019-2032, By Source

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Trend Analysis , By Source, 2019-2024
• 11.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast, By Source, 2025-2032
  • 11.3.1. Natural
  • 11.3.2. Synthetic
  • 11.3.3. Bio-Synthetic
• 11.4. Market Attractiveness Analysis By Source

12. Global Tryptamines API Market Outlook, 2019-2032, By Application

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Trend Analysis , By Application, 2019-2024
• 12.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast, By Application, 2025-2032
  • 12.3.1. Clinical Use
  • 12.3.2. Research Use
• 12.4. Market Attractiveness Analysis By Application

13. Global Tryptamines API Market Outlook, 2019-2032, By Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Trend Analysis , By Region, 2019-2024
• 13.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast, By Region, 2025-2032
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. East Asia
  • 13.3.5. South Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa
• 13.4. Market Attractiveness Analysis By Region

14. North America Tryptamines API Market Outlook, 2019-2032

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Trend Analysis , By Market Taxonomy, 2019-2024
• 14.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast, By Market Taxonomy, 2025-2032
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Grade
  • 14.3.3. By Source
  • 14.3.4. By Application
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Grade
  • 14.4.3. By Source
  • 14.4.4. By Application
• 14.5. Drivers and Restraints - Impact Analysis
• 14.6. Country Level Analysis & Forecast
  • 14.6.1. U.S. Tryptamines API Market
    • 14.6.1.1. Introduction
    • 14.6.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.6.1.2.1. By Grade
      • 14.6.1.2.2. By Source
      • 14.6.1.2.3. By Application
  • 14.6.2. Canada Tryptamines API Market
    • 14.6.2.1. Introduction
    • 14.6.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.6.2.2.1. By Grade
      • 14.6.2.2.2. By Source
      • 14.6.2.2.3. By Application

15. Latin America Tryptamines API Market Outlook, 2019-2032

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
• 15.3. Current and Future Market Size (US$ Mn) Trend Analysis & Forecast By Market Taxonomy, 2025-2032
  • 15.3.1. By Country
    • 15.3.1.1. Brazil
    • 15.3.1.2. Argentina
    • 15.3.1.3. Mexico
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Grade
  • 15.3.3. By Source
  • 15.3.4. By Application
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Grade
  • 15.4.3. By Source
  • 15.4.4. By Application
• 15.5. Drivers and Restraints - Impact Analysis
• 15.6. Country Level Analysis & Forecast
  • 15.6.1. Brazil Tryptamines API Market
    • 15.6.1.1. Introduction
    • 15.6.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.6.1.2.1. By Grade
      • 15.6.1.2.2. By Source
      • 15.6.1.2.3. By Application
  • 15.6.2. Argentina Tryptamines API Market
    • 15.6.2.1. Introduction
    • 15.6.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.6.2.2.1. By Grade
      • 15.6.2.2.2. By Source
      • 15.6.2.2.3. By Application
  • 15.6.3. Mexico Tryptamines API Market
    • 15.6.3.1. Introduction
    • 15.6.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.6.3.2.1. By Grade
      • 15.6.3.2.2. By Source
      • 15.6.3.2.3. By Application

16. Europe Tryptamines API Market Outlook, 2019-2032

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
• 16.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2025-2032
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. Italy
    • 16.3.1.3. France
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. BENELUX
    • 16.3.1.7. Nordic Countries
    • 16.3.1.8. Russia
    • 16.3.1.9. Rest of Europe
  • 16.3.2. By Grade
  • 16.3.3. By Source
  • 16.3.4. By Application
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Grade
  • 16.4.3. By Source
  • 16.4.4. By Application
• 16.5. Drivers and Restraints - Impact Analysis
• 16.6. Country Level Analysis & Forecast
  • 16.6.1. Germany Tryptamines API Market
    • 16.6.1.1. Introduction
    • 16.6.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.6.1.2.1. By Grade
      • 16.6.1.2.2. By Source
      • 16.6.1.2.3. By Application
  • 16.6.2. France Tryptamines API Market
    • 16.6.2.1. Introduction
    • 16.6.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.6.2.2.1. By Grade
      • 16.6.2.2.2. By Source
      • 16.6.2.2.3. By Application
  • 16.6.3. Italy Tryptamines API Market
    • 16.6.3.1. Introduction
    • 16.6.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.6.3.2.1. By Grade
      • 16.6.3.2.2. By Source
      • 16.6.3.2.3. By Application
  • 16.6.4. Spain Tryptamines API Market
    • 16.6.4.1. Introduction
    • 16.6.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.6.4.2.1. By Grade
      • 16.6.4.2.2. By Source
      • 16.6.4.2.3. By Application
  • 16.6.5. U.K. Tryptamines API Market
    • 16.6.5.1. Introduction
    • 16.6.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.6.5.2.1. By Grade
      • 16.6.5.2.2. By Source
      • 16.6.5.2.3. By Application
  • 16.6.6. BENULUX Tryptamines API Market
    • 16.6.6.1. Introduction
    • 16.6.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.6.6.2.1. By Grade
      • 16.6.6.2.2. By Source
      • 16.6.6.2.3. By Application
  • 16.6.7. Nordic Countries Tryptamines API Market
    • 16.6.7.1. Introduction
    • 16.6.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.6.7.2.1. By Grade
      • 16.6.7.2.2. By Source
      • 16.6.7.2.3. By Application
  • 16.6.8. Russia Tryptamines API Market
    • 16.6.8.1. Introduction
    • 16.6.8.2. Market Analysis and Forecast by Market Taxonomy
      • 16.6.8.2.1. By Grade
      • 16.6.8.2.2. By Source
      • 16.6.8.2.3. By Application

17. South Asia Tryptamines API Market Outlook, 2019-2032

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
• 17.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2025-2032
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Thailand
    • 17.3.1.3. Indonesia
    • 17.3.1.4. Malaysia
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Grade
  • 17.3.3. By Source
  • 17.3.4. By Application
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Grade
  • 17.4.3. By Source
  • 17.4.4. By Application
• 17.5. Drivers and Restraints - Impact Analysis
• 17.6. Country Level Analysis & Forecast
  • 17.6.1. India Tryptamines API Market
    • 17.6.1.1. Introduction
    • 17.6.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.6.1.2.1. By Grade
      • 17.6.1.2.2. By Source
      • 17.6.1.2.3. By Application
  • 17.6.2. Indonesia Tryptamines API Market
    • 17.6.2.1. Introduction
    • 17.6.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.6.2.2.1. By Grade
      • 17.6.2.2.2. By Source
      • 17.6.2.2.3. By Application
  • 17.6.3. Malaysia Tryptamines API Market
    • 17.6.3.1. Introduction
    • 17.6.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.6.3.2.1. By Grade
      • 17.6.3.2.2. By Source
      • 17.6.3.2.3. By Application
  • 17.6.4. Thailand Tryptamines API Market
    • 17.6.4.1. Introduction
    • 17.6.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.6.4.2.1. By Grade
      • 17.6.4.2.2. By Source
      • 17.6.4.2.3. By Application

18. East Asia Tryptamines API Market Outlook, 2019-2032

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
• 18.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2025-2032
  • 18.3.1. By Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
  • 18.3.2. By Grade
  • 18.3.3. By Source
  • 18.3.4. By Application
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Grade
  • 18.4.3. By Source
  • 18.4.4. By Application
• 18.5. Drivers and Restraints - Impact Analysis
• 18.6. Country Level Analysis & Forecast
  • 18.6.1. China Tryptamines API Market
    • 18.6.1.1. Introduction
    • 18.6.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.6.1.2.1. By Grade
      • 18.6.1.2.2. By Source
      • 18.6.1.2.3. By Application
  • 18.6.2. Japan Tryptamines API Market
    • 18.6.2.1. Introduction
    • 18.6.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.6.2.2.1. By Grade
      • 18.6.2.2.2. By Source
      • 18.6.2.2.3. By Application
  • 18.6.3. South Korea Tryptamines API Market
    • 18.6.3.1. Introduction
    • 18.6.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.6.3.2.1. By Grade
      • 18.6.3.2.2. By Source
      • 18.6.3.2.3. By Application

19. Oceania Tryptamines API Market Outlook, 2019-2032

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
• 19.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2025-2032
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Grade
  • 19.3.3. By Source
  • 19.3.4. By Compound
  • 19.3.5. By Application
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Grade
  • 19.4.3. By Source
  • 19.4.4. By Application
• 19.5. Drivers and Restraints - Impact Analysis
• 19.6. Country Level Analysis & Forecast
  • 19.6.1. Australia Tryptamines API Market
    • 19.6.1.1. Introduction
    • 19.6.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.6.1.2.1. By Grade
      • 19.6.1.2.2. By Source
      • 19.6.1.2.3. By Application
  • 19.6.2. New Zealand Tryptamines API Market
    • 19.6.2.1. Introduction
    • 19.6.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.6.2.2.1. By Grade
      • 19.6.2.2.2. By Source
      • 19.6.2.2.3. By Application

20. Middle East and Africa (MEA) Tryptamines API Market Outlook, 2019-2032

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
• 20.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2025-2032
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkey
    • 20.3.1.3. North Africa
    • 20.3.1.4. South Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Grade
  • 20.3.3. By Source
  • 20.3.4. By Application
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Grade
  • 20.4.3. By Source
  • 20.4.4. By Application
• 20.5. Drivers and Restraints - Impact Analysis
• 20.6. Country Level Analysis & Forecast
  • 20.6.1. GCC Countries Tryptamines API Market
    • 20.6.1.1. Introduction
    • 20.6.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.6.1.2.1. By Grade
      • 20.6.1.2.2. By Source
      • 20.6.1.2.3. By Application
  • 20.6.2. Turkey Tryptamines API Market
    • 20.6.2.1. Introduction
    • 20.6.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.6.2.2.1. By Grade
      • 20.6.2.2.2. By Source
      • 20.6.2.2.3. By Application
  • 20.6.3. South Africa Tryptamines API Market
    • 20.6.3.1. Introduction
    • 20.6.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.6.3.2.1. By Grade
      • 20.6.3.2.2. By Source
      • 20.6.3.2.3. By Application
  • 20.6.4. North Africa Tryptamines API Market
    • 20.6.4.1. Introduction
    • 20.6.4.2. Market Analysis and Forecast by Market Taxonomy
      • 20.6.4.2.1. By Grade
      • 20.6.4.2.2. By Source
      • 20.6.4.2.3. By Application

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Benchmarking
• 21.3. Competition Deep Dive
  • 21.3.1. Merck
    • 21.3.1.1. Company Overview
    • 21.3.1.2. Product Portfolio
    • 21.3.1.3. Key Financials
    • 21.3.1.4. SWOT Analysis
    • 21.3.1.5. Key Developments
  • 21.3.2. Avra Synthesis Private Limited
    • 21.3.2.1. Company Overview
    • 21.3.2.2. Product Portfolio
    • 21.3.2.3. Key Financials
    • 21.3.2.4. SWOT Analysis
    • 21.3.2.5. Key Developments
  • 21.3.3. Spectrum Chemical
    • 21.3.3.1. Company Overview
    • 21.3.3.2. Product Portfolio
    • 21.3.3.3. Key Financials
    • 21.3.3.4. SWOT Analysis
    • 21.3.3.5. Key Developments
  • 21.3.4. Cayman Chemical Company (Matreya)
    • 21.3.4.1. Company Overview
    • 21.3.4.2. Product Portfolio
    • 21.3.4.3. Key Financials
    • 21.3.4.4. SWOT Analysis
    • 21.3.4.5. Key Developments
  • 21.3.5. Tokyo Chemical Industry Co. Ltd.
    • 21.3.5.1. Company Overview
    • 21.3.5.2. Product Portfolio
    • 21.3.5.3. Key Financials
    • 21.3.5.4. SWOT Analysis
    • 21.3.5.5. Key Developments
  • 21.3.6. Santa Cruz Biotechnology, Inc.
    • 21.3.6.1. Company Overview
    • 21.3.6.2. Product Portfolio
    • 21.3.6.3. Key Financials
    • 21.3.6.4. SWOT Analysis
    • 21.3.6.5. Key Developments
  • 21.3.7. LGC Standards
    • 21.3.7.1. Company Overview
    • 21.3.7.2. Product Portfolio
    • 21.3.7.3. Key Financials
    • 21.3.7.4. SWOT Analysis
    • 21.3.7.5. Key Developments
  • 21.3.8. Avra Synthesis Private Limited
    • 21.3.8.1. Company Overview
    • 21.3.8.2. Product Portfolio
    • 21.3.8.3. Key Financials
    • 21.3.8.4. SWOT Analysis
    • 21.3.8.5. Key Developments
  • 21.3.9. SimSon Pharma Limited
    • 21.3.9.1. Company Overview
    • 21.3.9.2. Product Portfolio
    • 21.3.9.3. Key Financials
    • 21.3.9.4. SWOT Analysis
    • 21.3.9.5. Key Developments
  • 21.3.10. Glentham Life
    • 21.3.10.1. Company Overview
    • 21.3.10.2. Product Portfolio
    • 21.3.10.3. Key Financials
    • 21.3.10.4. SWOT Analysis
    • 21.3.10.5. Key Developments
  • 21.3.11. Clearsynth Labs
    • 21.3.11.1. Company Overview
    • 21.3.11.2. Product Portfolio
    • 21.3.11.3. Key Financials
    • 21.3.11.4. SWOT Analysis
    • 21.3.11.5. Key Developments
  • 21.3.12. Otto Chemie Pvt. Ltd
    • 21.3.12.1. Company Overview
    • 21.3.12.2. Product Portfolio
    • 21.3.12.3. Key Financials
    • 21.3.12.4. SWOT Analysis
    • 21.3.12.5. Key Developments
  • 21.3.13. Pharmaffiliates Analytics and Synthetics P. Ltd.
    • 21.3.13.1. Company Overview
    • 21.3.13.2. Product Portfolio
    • 21.3.13.3. Key Financials
    • 21.3.13.4. SWOT Analysis
    • 21.3.13.5. Key Developments
  • 21.3.14. Psygen
    • 21.3.14.1. Company Overview
    • 21.3.14.2. Product Portfolio
    • 21.3.14.3. Key Financials
    • 21.3.14.4. SWOT Analysis
    • 21.3.14.5. Key Developments
  • 21.3.15. Biosynth
    • 21.3.15.1. Company Overview
    • 21.3.15.2. Product Portfolio
    • 21.3.15.3. Key Financials
    • 21.3.15.4. SWOT Analysis
    • 21.3.15.5. Key Developments

22. Assumptions and Acronyms Used

23. Research Methodology

관련자료